Author:
Chen Haifeng,Zhou Shiliang,Su Dinglei,Lu Liwei,Li Xia,Sun Lingyun
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference32 articles.
1. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558
2. Cornec D, Devauchelle-Pensec V, Tobon GJ, Pers JO, Jousse-Joulin S, Saraux A (2012) B cells in Sjogren’s syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun 39:161–167
3. Devauchelle-Pensec V, Pennec Y, Morvan J, Pers JO, Daridon C, Jousse-Joulin S et al (2007) Improvement of Sjogren’s syndrome after two infusions of rituximab (anti-CD20). Arthritis Rheum 57:310–317
4. Devauchelle-Pensec V, Morvan J, Rat AC, Jousse-Joulin S, Pennec Y, Pers JO et al (2011) Effects of rituximab therapy on quality of life in patients with primary Sjogren’s syndrome. Clin Exp Rheumatol 29:6–12
5. Voulgarelis M, Tzioufas AG (2010) Pathogenetic mechanisms in the initiation and perpetuation of Sjogren’s syndrome. Nat Rev Rheumatol 6:529–537
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献